The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

 Cardiome Pharma Corp.  (CRME) Trade Now »     Rate CRME  -  Discuss CRME  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
80.0%
Top:
100.0%
Rate CRME:



Who've Rated CRME All   |   Bullish   |   Bearish   |   Hold

Name Rank Rating Return Start Closed
Foto
Marian Filo 62% Positive -94.23% 05/21/10 --
mulder N/A Positive -89.63% 10/29/09 --
Gordon_gekko
Summerof69 59% Positive -90.23% 10/04/09 --
othnielm 78% Positive -89.53% 04/11/09 --
othnielm 78% Positive +0.00% 04/11/09 04/11/09
Mikerun
Mike Havrilla 73% Positive -89.66% 04/10/09 --
Mike Havrilla 44% Positive -96.40% 08/07/08 --
chrs2us N/A Positive -96.21% 07/17/08 --
Linda  7 % Negative +95.13% 07/10/08 --
Linda  7 % Negative +0.11% 07/10/08 07/10/08
Linda  7 % Positive -13.68% 05/09/08 07/10/08
brigar N/A Positive -94.05% 04/16/08 --
Gavin_2_mos_017
Somarsiryc 16% Positive -95.38% 08/07/07 --


ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on CRME

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Cardiome Pharma Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch